mDETECT Inc.

mDETECT is a DNA-methylation-based liquid biopsy company that has developed a highly specific and sensitive blood test for the detection and management of metastatic breast cancer. The test can rapidly and accurately determine the tumor burden in patients to assess therapy response. Blood tests for prostate cancer and

Operating in biomedical engineering, cancer, mDETECT Inc. operates.

Profile

mDETECT is a DNA-methylation-based liquid biopsy company that has developed a highly specific and sensitive blood test for the detection and management of metastatic breast cancer. The test can rapidly and accurately determine the tumor burden in patients to assess therapy response. Blood tests for prostate cancer and uveal melanoma are also part of the […]

Within the biomedical engineering, cancer space, the company focuses on its core offering rather than a broad product line.

It is recorded at the Creative Destruction Lab alumni company stage.

Website: www.mdetect-inc.com